RUBICON Share Price | Rubicon Research Ltd Stock Analysis & Recommendation

Q: Why is Rubicon Research Ltd falling/rising?

As of 07-Feb, Rubicon Research Ltd's stock price is currently falling, with a change of -4.05, which represents a decrease of 0.51%. This decline follows a trend reversal after four consecutive days of gains, indicating a potential correction in the stock's price movement. Despite this recent drop, the stock has shown strong performance over various periods, outperforming the Sensex by 14.84% over the past week and 18.25% over the past month. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a generally positive trend prior to this decline.Investor participation has also increased, with a notable rise in delivery volume by 85.47% against the 5-day average, indicating heightened interest in the stock. However, the current price drop may reflect a natural market correction after a period of strong performance. Overall, while the stock is experiencing a temporary decline, its recent strong performance and increased investor activity suggest underlying strength in the company's position.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.52 lacs (-76.32%) Volume

Shareholding (Dec 2025)

FII

7.99%

Held by 42 FIIs

DII

2.44%

Held by 11 DIIs

Promoter

59.99%

When is the next results date for Rubicon Research Ltd?

28-Jan-2026

The next results date for Rubicon Research Ltd is 03 February 2026.

View full answer

Why is Rubicon Research Ltd falling/rising?

07-Feb-2026

As of 07-Feb, Rubicon Research Ltd's stock is experiencing a decline of 0.51% after a period of gains, indicating a potential market correction. Despite this drop, the stock has outperformed the Sensex recently and shows strong investor interest, suggesting underlying strength.

View full answer

Which are the latest news on Rubicon Research?

08-Feb-2026

When is the next results date for Rubicon Research Ltd?

Compare Rubicon Research with Similar Stocks

OneSource Speci.Concord Biotech Cohance Life

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 12,898 Cr (Mid Cap)

P/E

77.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.60

Return on Equity

22.13%

Price to Book

17.16

Revenue and Profits:

Net Sales:

476 Cr

(Quarterly Results - Dec 2025)

Net Profit:

73 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

23.04%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Rubicon Research for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Rubicon Research Ltd?

The next results date for Rubicon Research Ltd is scheduled for 03 February 2026....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

06-Feb-2026 | Source : BSE

Earnings Call - Q3 FY 2025-26

Newspaper Publication - Financial Results

05-Feb-2026 | Source : BSE

Newspaper Publication - Financial Results

Results - Financial Results For 31-12-2025

03-Feb-2026 | Source : BSE

Financial Results for Quarter ended December 31 2025.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

6.94

Debt to EBITDA (avg)

2.05

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.27

Tax Ratio

24.96%

Dividend Payout Ratio

0.23%

Pledged Shares

Institutional Holding

17.44%

ROCE (avg)

22.12%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

17.07

EV to EBIT

56.23

EV to EBITDA

49.56

EV to Capital Employed

11.07

EV to Sales

12.46

PEG Ratio

Dividend Yield

ROCE (Latest)

19.68%

ROE (Latest)

22.13%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (6.61%)

FIIs

Held by 42 FIIs (7.99%)

Promoter with highest holding

General Atlantic Singapore Rr Pte Ltd (35.97%)

Highest Public shareholder

Shivanand Shankar Mankekar Huf (13.57%)

Individual Investors Holdings

2.71%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -10.33% vs 21.02% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -18.84% vs 30.33% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "301.71",
          "val2": "336.47",
          "chgp": "-10.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "62.24",
          "val2": "79.11",
          "chgp": "-21.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.51",
          "val2": "9.21",
          "chgp": "-18.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "37.18",
          "val2": "45.81",
          "chgp": "-18.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.63%",
          "val2": "23.51%",
          "chgp": "-2.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "614.49",
          "val2": "528.16",
          "chgp": "16.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "142.24",
          "val2": "144.68",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.06",
          "val2": "16.26",
          "chgp": "11.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "80.96",
          "val2": "89.04",
          "chgp": "-9.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.15%",
          "val2": "27.39%",
          "chgp": "-4.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "916.20",
          "val2": "773.03",
          "chgp": "18.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.48",
          "val2": "208.58",
          "chgp": "-1.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "25.57",
          "val2": "23.51",
          "chgp": "8.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "118.14",
          "val2": "127.27",
          "chgp": "-7.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.32%",
          "val2": "26.98%",
          "chgp": "-4.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,073.84",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "269.89",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "34.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "167.54",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.13%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

301.71

336.47

-10.33%

Operating Profit (PBDIT) excl Other Income

62.24

79.11

-21.32%

Interest

7.51

9.21

-18.46%

Exceptional Items

0.00

Standalone Net Profit

37.18

45.81

-18.84%

Operating Profit Margin (Excl OI)

20.63%

23.51%

-2.88%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -10.33% vs 21.02% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -18.84% vs 30.33% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

614.49

528.16

16.35%

Operating Profit (PBDIT) excl Other Income

142.24

144.68

-1.69%

Interest

18.06

16.26

11.07%

Exceptional Items

0.00

Standalone Net Profit

80.96

89.04

-9.07%

Operating Profit Margin (Excl OI)

23.15%

27.39%

-4.24%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

916.20

773.03

18.52%

Operating Profit (PBDIT) excl Other Income

204.48

208.58

-1.97%

Interest

25.57

23.51

8.76%

Exceptional Items

0.00

Standalone Net Profit

118.14

127.27

-7.17%

Operating Profit Margin (Excl OI)

22.32%

26.98%

-4.66%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

1,073.84

Operating Profit (PBDIT) excl Other Income

269.89

Interest

34.29

Exceptional Items

0.00

Standalone Net Profit

167.54

Operating Profit Margin (Excl OI)

25.13%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Rubicon Research Ltd

Rubicon Research Ltd

Mid Cap

Pharmaceuticals & Biotechnology

Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as `Rubicon Consultants Private Limited', with the RoC. Subsequently, the Company's name was changed from `Rubicon Consultants Private Limited' to `Rubicon Research Private Limited' to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002.

Company Coordinates

No Company Details Available

Rubicon Research

1Day

52 Week

CASH

FII

DII

Promoter

When is the next results date for Rubicon Research Ltd?

Watch in Real-Time

Why is Rubicon Research Ltd falling/rising?

Which are the latest news on Rubicon Research?

Compare Rubicon Research with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

When is the next results date for Rubicon Research Ltd?

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Newspaper Publication - Financial Results

Results - Financial Results For 31-12-2025

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Half Yearly Results Snapshot (Standalone) - Sep'25

Nine Monthly Results Snapshot (Standalone) - Dec'25

Annual Results Snapshot (Standalone) - Mar'25

About Rubicon Research Ltd

Company Coordinates